Prostate Cancer: Epidemiology and Pathogenesis: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 11: | Line 11: | ||
** '''<span style="color:#ff0000">Most common malignancy in men</span>''' | ** '''<span style="color:#ff0000">Most common malignancy in men</span>''' | ||
***Lung and bronchus cancer second most common | ***Lung and bronchus cancer second most common | ||
** '''Estimated incidence 2023: 288,300[https://pubmed.ncbi.nlm.nih.gov/36633525/] | ** '''Estimated incidence 2024: 299,010[https://pubmed.ncbi.nlm.nih.gov/38230766/]''' (2023: 288,300[https://pubmed.ncbi.nlm.nih.gov/36633525/], 2022: 268,490) | ||
*** '''≈1/8 males are diagnosed with prostate cancer during their lifetime''' | *** '''≈1/8 males are diagnosed with prostate cancer during their lifetime''' | ||
**Projected incidence 2040: 66,000[https://pubmed.ncbi.nlm.nih.gov/33825840/] | **Projected incidence 2040: 66,000[https://pubmed.ncbi.nlm.nih.gov/33825840/] | ||